| | Age (mean ± SD) | 55.4 ± 8.96 | | Males, n (%) | 21 (84) | | MI anatomical localization | | Anterior wall, n (%) | 11 (44) | | Lateral wall, n (%) | 13 (52) | | Anterolateral wall, n (%) | 1 (4) | | MI complicated with a cardiac arrest, n (%) | 2 (8) | | MI complicated with a cardiogenic shock, n (%) | 1 (4) |
| | CAD | | Single vessel, n (%) | 15 (60) | | Double vessel, n (%) | 8 (32) | | Triple vessel, n (%) | 2 (8) |
| | Infarct-related artery with stent(s) implantation | | Left anterior descending artery, n (%) | 12 (48) | | Right coronary artery, n (%) | 13 (52) | | ≥2 vessels, n (%) | 3 (12) |
| | CAD risk factors | | Hypertension, n (%) | 14 (56) | | Dyslipidemia, n (%) | 5 (20) | | Diabetes, n (%) | 3 (12) | | Obesity, n (%) | 3 (12) | | Family history of CAD, n (%) | 3 (12.5) | | Current smoker, n (%) | 12 (48) |
| | Pharmacotherapy at discharge | | Angiotensin-converting enzyme inhibitor, n (%) | 24 (96) | | B-blocker, n (%) | 23 (92) | | Statin, n (%) | 25 (100) | | Aspirin, n (%) | 25 (100) | | Clopidogrel, n (%) | 25 (100) | | Calcium channel blocker n (%) | 2 (8) | | Diuretic, n (%) | 4 (16) |
|
|
